Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-422 Cr₹818 Cr₹794 Cr₹3,977 Cr

What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA is ₹-422 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-422 Cr
Mar2023₹818 Cr
Mar2022₹794 Cr
Mar2021₹3,977 Cr

How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-422 Cr
Negative
Mar2023 ₹818 Cr
2.97
Mar2022 ₹794 Cr
-80.03
Mar2021 ₹3,977 Cr -

Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹25,680.1 Cr -3.4% -6.1% 27.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,326.0 Cr -2.3% -3.5% 9.2% Stock Analytics
DIVIS LABORATORIES ₹173,562.0 Cr -2.8% 1.3% 42.3% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 3% -2.6% Stock Analytics
DR REDDYS LABORATORIES ₹109,558.0 Cr -3.7% 7.2% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,204.0 Cr -1% -0.5% 13.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-3.4%

-6.1%

27.4%

SENSEX

-1.3%

-0.8%

6.3%


You may also like the below Video Courses